$2.59 0.08 (+3.18%)
12/3/2009 3:59 PM

EXACT Sciences Corp (EXAS)

CAPS Rating: 5 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

3
Member Avatar wymichael (48.32) Submitted: 11/2/2007 7:28:03 PM : Outperform Start Price: $4.23 EXAS Score: -16.05

Let's see, would you prefer an invasive test for colon cancer, or a non-invasive one?

Report this Post 0 Comments

Featured Broker Partners